Implementing screening for myocardial injury in non-cardiac surgery : perspectives of an ad-hoc interdisciplinary expert group
Objectives. Perioperative myocardial injury (PMI) is increasingly recognised as an important complication of non-cardiac surgery, with often clinically silent presentation, but detrimental prognosis. Active screening for PMI, involving the detection of dynamic and elevated levels of cardiac troponin, has recently been advocated by an increasing number of guidelines; however, active PMI screening has not been reflected in clinical practice. Design. As consensus on a common screening and management pathway is lacking, we synthesise the current evidence to provide suggestions on the selection of patients for screening, organisation of a screening program, and a potential management pathway, building upon a recently published perioperative screening algorithm. Results. Screening should be performed using high-sensitivity assays both preoperatively and postoperatively (postoperative Days 1 and 2) in patients at high-risk of experiencing perioperative complications. Conclusion. This expert opinion piece by an interdisciplinary group of predominantly Norwegian clinicians aims to assist healthcare professionals planning to implement guideline-recommended PMI screening at a local level in order to improve patient outcomes following non-cardiac surgery.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
---|---|
Enthalten in: |
Scandinavian cardiovascular journal : SCJ - 57(2023), 1 vom: 01. Dez., Seite 31-39 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Atar, Dan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardiac troponin |
---|
Anmerkungen: |
Date Completed 08.05.2023 Date Revised 17.05.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1080/14017431.2022.2112071 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356443574 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356443574 | ||
003 | DE-627 | ||
005 | 20231226070455.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/14017431.2022.2112071 |2 doi | |
028 | 5 | 2 | |a pubmed24n1188.xml |
035 | |a (DE-627)NLM356443574 | ||
035 | |a (NLM)37141087 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Atar, Dan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Implementing screening for myocardial injury in non-cardiac surgery |b perspectives of an ad-hoc interdisciplinary expert group |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.05.2023 | ||
500 | |a Date Revised 17.05.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Objectives. Perioperative myocardial injury (PMI) is increasingly recognised as an important complication of non-cardiac surgery, with often clinically silent presentation, but detrimental prognosis. Active screening for PMI, involving the detection of dynamic and elevated levels of cardiac troponin, has recently been advocated by an increasing number of guidelines; however, active PMI screening has not been reflected in clinical practice. Design. As consensus on a common screening and management pathway is lacking, we synthesise the current evidence to provide suggestions on the selection of patients for screening, organisation of a screening program, and a potential management pathway, building upon a recently published perioperative screening algorithm. Results. Screening should be performed using high-sensitivity assays both preoperatively and postoperatively (postoperative Days 1 and 2) in patients at high-risk of experiencing perioperative complications. Conclusion. This expert opinion piece by an interdisciplinary group of predominantly Norwegian clinicians aims to assist healthcare professionals planning to implement guideline-recommended PMI screening at a local level in order to improve patient outcomes following non-cardiac surgery | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a PMI | |
650 | 4 | |a Perioperative screening | |
650 | 4 | |a cardiac troponin | |
650 | 4 | |a myocardial infarction | |
650 | 4 | |a myocardial injury | |
700 | 1 | |a Rosseland, Leiv Arne |e verfasserin |4 aut | |
700 | 1 | |a Jammer, Ib |e verfasserin |4 aut | |
700 | 1 | |a Aakre, Kristin Moberg |e verfasserin |4 aut | |
700 | 1 | |a Wiseth, Rune |e verfasserin |4 aut | |
700 | 1 | |a Molund, Marius |e verfasserin |4 aut | |
700 | 1 | |a Gualandro, Danielle M |e verfasserin |4 aut | |
700 | 1 | |a Omland, Torbjørn |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Scandinavian cardiovascular journal : SCJ |d 1998 |g 57(2023), 1 vom: 01. Dez., Seite 31-39 |w (DE-627)NLM091266157 |x 1651-2006 |7 nnns |
773 | 1 | 8 | |g volume:57 |g year:2023 |g number:1 |g day:01 |g month:12 |g pages:31-39 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/14017431.2022.2112071 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 57 |j 2023 |e 1 |b 01 |c 12 |h 31-39 |